Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration

David O'Sullivan1, John H Miller, Peter T Northcote

  • 1Centre for Biodiscovery, Schools of Biological Sciences and Chemical and Physical Sciences, Victoria University of Wellington, Wellington, New Zealand.

Immunology and Cell Biology
|September 25, 2013
PubMed

Insights

Microtubule-stabilizing agents (MSA) protect against experimental autoimmune encephalomyelitis (EAE) by inhibiting immune cell migration into the central nervous system (CNS) and preventing proliferation. Combination therapies with synergistic MSA enhance protection at lower doses.

Area of Science:

  • Immunology
  • Neuroscience
  • Pharmacology

Background:

  • Microtubule-stabilizing agents (MSA) are anti-proliferative compounds previously shown to delay disease onset and reduce cumulative disease in experimental autoimmune encephalomyelitis (EAE).
  • The precise mechanisms by which MSA exert their protective effects in EAE remain incompletely understood.

Purpose of the Study:

  • To investigate the mechanisms of action of MSA in EAE.
  • To determine if the protective effects of MSA are solely due to their anti-proliferative activity.
  • To explore the potential for synergistic effects between different MSA.

Main Methods:

  • Comparison of MSA administration before or after peak antigen-specific proliferation in an EAE model.
  • In vivo migration assays to assess immune cell infiltration into the central nervous system (CNS).
  • Evaluation of combination therapy using different MSA (peloruside A and ixabepilone).

Main Results:

  • Treatment with MSA before peak proliferation inhibited antigen-specific responses in the spleen, while treatment after peak proliferation did not.
  • Despite differences in proliferation inhibition, both treatment timings resulted in similar protection against EAE.
  • MSA were shown to inhibit immune cell infiltration into the CNS.
  • Combination treatment with low doses of two different MSA (peloruside A and ixabepilone) enhanced efficacy and synergized in vivo.

Conclusions:

  • The protective effect of MSA in EAE is not solely attributed to anti-proliferative activity.
  • MSA suppress EAE through at least two mechanisms: prevention of proliferation and inhibition of immune cell migration into the CNS.
  • Combination therapy with synergizing MSA offers enhanced protection at lower therapeutic doses, suggesting a promising therapeutic strategy for EAE.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Microtubules in Cell Motility01:24

Microtubules in Cell Motility

Microtubules are thick hollow cylindrical proteins that help form the cytoskeleton. Microtubules have varied roles in the cell. These filaments help form cellular appendages like cilia and flagella, which are responsible for locomotion. The cilia arise from basal bodies, separated from the main body by a membrane-like structure forming the transition zone. This zone is the gate for the entry of lipids and proteins, creating a unique composition of lipids and proteins in the ciliary membrane and...